

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 7.93547489 |
| 2 | actin-myosin filament sliding (GO:0033275) | 7.48662615 |
| 3 | muscle filament sliding (GO:0030049) | 7.48662615 |
| 4 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 7.34700483 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 6.92640320 |
| 6 | cardiac myofibril assembly (GO:0055003) | 6.84850266 |
| 7 | tricarboxylic acid cycle (GO:0006099) | 6.75876333 |
| 8 | myofibril assembly (GO:0030239) | 6.75190866 |
| 9 | carnitine shuttle (GO:0006853) | 6.72437833 |
| 10 | behavioral response to nicotine (GO:0035095) | 6.69675721 |
| 11 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.59946900 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.50307164 |
| 13 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 6.18725307 |
| 14 | actin-mediated cell contraction (GO:0070252) | 6.16862908 |
| 15 | plasma membrane repair (GO:0001778) | 6.13777700 |
| 16 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 6.06792839 |
| 17 | fatty acid transmembrane transport (GO:1902001) | 6.02827383 |
| 18 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.95582553 |
| 19 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.87896026 |
| 20 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.75941531 |
| 21 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.62520134 |
| 22 | cardiac muscle contraction (GO:0060048) | 5.57612528 |
| 23 | regulation of sequestering of triglyceride (GO:0010889) | 5.51336037 |
| 24 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.34714465 |
| 25 | water-soluble vitamin biosynthetic process (GO:0042364) | 5.25991304 |
| 26 | regulation of relaxation of muscle (GO:1901077) | 5.20673179 |
| 27 | cardiac muscle cell development (GO:0055013) | 5.15983310 |
| 28 | regulation of coenzyme metabolic process (GO:0051196) | 5.13497093 |
| 29 | regulation of cofactor metabolic process (GO:0051193) | 5.13497093 |
| 30 | carnitine transmembrane transport (GO:1902603) | 5.11780311 |
| 31 | striated muscle contraction (GO:0006941) | 5.07153538 |
| 32 | regulation of actin filament-based movement (GO:1903115) | 5.05066055 |
| 33 | actomyosin structure organization (GO:0031032) | 5.02733050 |
| 34 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.90413712 |
| 35 | somite development (GO:0061053) | 4.85786237 |
| 36 | cardiac cell development (GO:0055006) | 4.84416207 |
| 37 | creatine metabolic process (GO:0006600) | 4.78255450 |
| 38 | regulation of cell communication by electrical coupling (GO:0010649) | 4.78187938 |
| 39 | NADH metabolic process (GO:0006734) | 4.76223342 |
| 40 | skeletal muscle contraction (GO:0003009) | 4.72961100 |
| 41 | amino-acid betaine transport (GO:0015838) | 4.71576384 |
| 42 | carnitine transport (GO:0015879) | 4.71576384 |
| 43 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.66726361 |
| 44 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.66318071 |
| 45 | actin filament-based movement (GO:0030048) | 4.63886746 |
| 46 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.51101474 |
| 47 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.45320499 |
| 48 | 2-oxoglutarate metabolic process (GO:0006103) | 4.37779511 |
| 49 | cardiac muscle hypertrophy (GO:0003300) | 4.37117150 |
| 50 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.36528477 |
| 51 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.34279938 |
| 52 | adult heart development (GO:0007512) | 4.31316779 |
| 53 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.23620452 |
| 54 | striated muscle hypertrophy (GO:0014897) | 4.23427905 |
| 55 | heart trabecula formation (GO:0060347) | 4.19641212 |
| 56 | regulation of striated muscle contraction (GO:0006942) | 4.18611544 |
| 57 | regulation of sulfur metabolic process (GO:0042762) | 4.16869233 |
| 58 | fatty acid beta-oxidation (GO:0006635) | 4.15866856 |
| 59 | otic vesicle formation (GO:0030916) | 4.13622618 |
| 60 | skeletal muscle adaptation (GO:0043501) | 4.11597583 |
| 61 | regulation of sarcomere organization (GO:0060297) | 4.09049603 |
| 62 | cell proliferation in forebrain (GO:0021846) | 4.07829086 |
| 63 | regulation of fatty acid oxidation (GO:0046320) | 4.04875427 |
| 64 | muscle tissue morphogenesis (GO:0060415) | 4.03113484 |
| 65 | heart process (GO:0003015) | 3.97225201 |
| 66 | heart contraction (GO:0060047) | 3.97225201 |
| 67 | protein complex biogenesis (GO:0070271) | 3.93616338 |
| 68 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.93268228 |
| 69 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.92766011 |
| 70 | regulation of membrane repolarization (GO:0060306) | 3.80283966 |
| 71 | biotin metabolic process (GO:0006768) | 3.77932841 |
| 72 | muscle contraction (GO:0006936) | 3.76645138 |
| 73 | muscle hypertrophy (GO:0014896) | 3.72471341 |
| 74 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.68981334 |
| 75 | glycogen catabolic process (GO:0005980) | 3.68334668 |
| 76 | succinate metabolic process (GO:0006105) | 3.66931973 |
| 77 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.66431987 |
| 78 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.66199550 |
| 79 | membrane repolarization during action potential (GO:0086011) | 3.61575088 |
| 80 | intracellular protein transmembrane import (GO:0044743) | 3.61282723 |
| 81 | primary amino compound metabolic process (GO:1901160) | 3.58918280 |
| 82 | respiratory electron transport chain (GO:0022904) | 3.58771393 |
| 83 | positive regulation of glomerulus development (GO:0090193) | 3.58612797 |
| 84 | oxidative phosphorylation (GO:0006119) | 3.57041149 |
| 85 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.56536695 |
| 86 | serotonin metabolic process (GO:0042428) | 3.55875481 |
| 87 | tricarboxylic acid metabolic process (GO:0072350) | 3.55854691 |
| 88 | negative regulation of response to food (GO:0032096) | 3.55459741 |
| 89 | negative regulation of appetite (GO:0032099) | 3.55459741 |
| 90 | valine metabolic process (GO:0006573) | 3.54920559 |
| 91 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.54815600 |
| 92 | regulation of the force of heart contraction (GO:0002026) | 3.54445526 |
| 93 | lipid particle organization (GO:0034389) | 3.53232783 |
| 94 | oxaloacetate metabolic process (GO:0006107) | 3.50970453 |
| 95 | branched-chain amino acid catabolic process (GO:0009083) | 3.48992073 |
| 96 | muscle system process (GO:0003012) | 3.48054079 |
| 97 | striated muscle adaptation (GO:0014888) | 3.47847955 |
| 98 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.47667155 |
| 99 | electron transport chain (GO:0022900) | 3.47636563 |
| 100 | cell communication involved in cardiac conduction (GO:0086065) | 3.45613795 |
| 101 | chaperone-mediated protein complex assembly (GO:0051131) | 3.44551964 |
| 102 | quaternary ammonium group transport (GO:0015697) | 3.44282776 |
| 103 | glucan catabolic process (GO:0009251) | 3.42712340 |
| 104 | positive regulation of fatty acid oxidation (GO:0046321) | 3.42451696 |
| 105 | fatty acid catabolic process (GO:0009062) | 3.40836252 |
| 106 | response to inactivity (GO:0014854) | 3.40194281 |
| 107 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.40173854 |
| 108 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.39646749 |
| 109 | lysine metabolic process (GO:0006553) | 3.37625081 |
| 110 | lysine catabolic process (GO:0006554) | 3.37625081 |
| 111 | intracellular lipid transport (GO:0032365) | 3.35761881 |
| 112 | striated muscle cell development (GO:0055002) | 3.35162047 |
| 113 | fatty acid oxidation (GO:0019395) | 3.35147896 |
| 114 | glucan biosynthetic process (GO:0009250) | 3.32435045 |
| 115 | glycogen biosynthetic process (GO:0005978) | 3.32435045 |
| 116 | aspartate family amino acid catabolic process (GO:0009068) | 3.32219226 |
| 117 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.32145555 |
| 118 | muscle hypertrophy in response to stress (GO:0003299) | 3.32145555 |
| 119 | cardiac muscle adaptation (GO:0014887) | 3.32145555 |
| 120 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.30150141 |
| 121 | cellular anion homeostasis (GO:0030002) | 3.29901178 |
| 122 | lipid oxidation (GO:0034440) | 3.28520167 |
| 123 | branched-chain amino acid metabolic process (GO:0009081) | 3.28433506 |
| 124 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.27956957 |
| 125 | negative regulation of potassium ion transport (GO:0043267) | 3.26843247 |
| 126 | negative regulation of membrane potential (GO:0045837) | 3.25551093 |
| 127 | regulation of glomerulus development (GO:0090192) | 3.24859662 |
| 128 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.19076063 |
| 129 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.16321244 |
| 130 | response to muscle activity (GO:0014850) | 3.13859407 |
| 131 | tooth mineralization (GO:0034505) | 3.13842637 |
| 132 | membrane depolarization during action potential (GO:0086010) | 3.08084150 |
| 133 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.06800763 |
| 134 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.06800763 |
| 135 | protein polyglutamylation (GO:0018095) | 3.06081835 |
| 136 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.04550779 |
| 137 | NADH dehydrogenase complex assembly (GO:0010257) | 3.04550779 |
| 138 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.04550779 |
| 139 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.00899420 |
| 140 | lateral sprouting from an epithelium (GO:0060601) | 3.00460188 |
| 141 | synaptic transmission, cholinergic (GO:0007271) | 2.99611131 |
| 142 | endoderm formation (GO:0001706) | 2.99249360 |
| 143 | lung morphogenesis (GO:0060425) | 2.97201726 |
| 144 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.94681088 |
| 145 | negative regulation of heart growth (GO:0061117) | 2.94681088 |
| 146 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.94566347 |
| 147 | positive regulation of fatty acid transport (GO:2000193) | 2.93803289 |
| 148 | positive regulation of T cell apoptotic process (GO:0070234) | 2.92672657 |
| 149 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.92197606 |
| 150 | intracellular protein transmembrane transport (GO:0065002) | 2.92189586 |
| 151 | membrane repolarization (GO:0086009) | 2.83842983 |
| 152 | gamma-aminobutyric acid transport (GO:0015812) | 2.79379623 |
| 153 | pharyngeal system development (GO:0060037) | 2.79312172 |
| 154 | parturition (GO:0007567) | 2.79219920 |
| 155 | transmission of nerve impulse (GO:0019226) | 2.77498877 |
| 156 | middle ear morphogenesis (GO:0042474) | 2.77416918 |
| 157 | DNA deamination (GO:0045006) | 2.77289254 |
| 158 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.75655331 |
| 159 | limb development (GO:0060173) | 2.75235402 |
| 160 | appendage development (GO:0048736) | 2.75235402 |
| 161 | multicellular organismal signaling (GO:0035637) | 2.72372668 |
| 162 | response to pheromone (GO:0019236) | 2.70158837 |
| 163 | protein import into peroxisome matrix (GO:0016558) | 2.68062385 |
| 164 | dentate gyrus development (GO:0021542) | 2.67650956 |
| 165 | kidney morphogenesis (GO:0060993) | 2.67538162 |
| 166 | regulation of mesoderm development (GO:2000380) | 2.66474552 |
| 167 | cytochrome complex assembly (GO:0017004) | 2.65938085 |
| 168 | neuromuscular synaptic transmission (GO:0007274) | 2.65163696 |
| 169 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.63266510 |
| 170 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.62275279 |
| 171 | regulation of action potential (GO:0098900) | 2.61841057 |
| 172 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.61738396 |
| 173 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.57795783 |
| 174 | regulation of potassium ion transport (GO:0043266) | 2.57738606 |
| 175 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.56555320 |
| 176 | dendritic spine morphogenesis (GO:0060997) | 2.54654902 |
| 177 | skeletal muscle fiber development (GO:0048741) | 2.54595452 |
| 178 | regulation of receptor binding (GO:1900120) | 2.53968325 |
| 179 | cardiac conduction (GO:0061337) | 2.53654804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.74559219 |
| 2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.25720030 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.30808755 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.83205815 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.71634908 |
| 6 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.59538746 |
| 7 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.50726141 |
| 8 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.50726141 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.20829095 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.93877189 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.91891344 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.88705265 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.55572972 |
| 14 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.48038895 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.48010358 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41993135 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39520627 |
| 18 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.35190511 |
| 19 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.35056267 |
| 20 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.28966645 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.17404522 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13451402 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.10085532 |
| 24 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.10013750 |
| 25 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.08446437 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.04653601 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.02778593 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.01389203 |
| 29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.96869306 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.96456739 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.94922109 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.92767796 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.92386045 |
| 34 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.89852339 |
| 35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.88456774 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.87766291 |
| 37 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.87093331 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85576754 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.85439422 |
| 40 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.83257374 |
| 41 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.83257374 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.82179258 |
| 43 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.81147743 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73834836 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.70943031 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70018874 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.68487576 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.67203503 |
| 49 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.67136273 |
| 50 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.67069335 |
| 51 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.65099015 |
| 52 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.64609170 |
| 53 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.64352855 |
| 54 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.61357236 |
| 55 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.61068862 |
| 56 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.58316317 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54553554 |
| 58 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.52327533 |
| 59 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.51080573 |
| 60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.49843017 |
| 61 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.48743522 |
| 62 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.48140493 |
| 63 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.44529360 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.40655612 |
| 65 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.40614362 |
| 66 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.40502716 |
| 67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.39202250 |
| 68 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35427982 |
| 69 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35066037 |
| 70 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.33737135 |
| 71 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32626012 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31444220 |
| 73 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.31376925 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30412947 |
| 75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.28247251 |
| 76 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.27989384 |
| 77 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.27920138 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26555928 |
| 79 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.26420210 |
| 80 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.26169559 |
| 81 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26076253 |
| 82 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.25705095 |
| 83 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25262463 |
| 84 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.23783199 |
| 85 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23530513 |
| 86 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.22134405 |
| 87 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.18719329 |
| 88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.18318387 |
| 89 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17798793 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16971307 |
| 91 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.15662694 |
| 92 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15301528 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12956494 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.12804722 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12760708 |
| 96 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12140908 |
| 97 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09499021 |
| 98 | NCOR_22424771_ChIP-Seq_293T_Human | 1.09309599 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09296152 |
| 100 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.09294512 |
| 101 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.06867741 |
| 102 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06402283 |
| 103 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.06227527 |
| 104 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.04938275 |
| 105 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04912274 |
| 106 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04912274 |
| 107 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04377503 |
| 108 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04250952 |
| 109 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03502394 |
| 110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03140383 |
| 111 | P300_19829295_ChIP-Seq_ESCs_Human | 1.03052647 |
| 112 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02958606 |
| 113 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02722444 |
| 114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01517504 |
| 115 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01389906 |
| 116 | P68_20966046_ChIP-Seq_HELA_Human | 1.00866061 |
| 117 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.00295087 |
| 118 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.00295087 |
| 119 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99734250 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99654120 |
| 121 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98973625 |
| 122 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98661507 |
| 123 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.98320008 |
| 124 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97700338 |
| 125 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.96824369 |
| 126 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96233257 |
| 127 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95316228 |
| 128 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.93785213 |
| 129 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93449858 |
| 130 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93052903 |
| 131 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92818421 |
| 132 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92805698 |
| 133 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92801067 |
| 134 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.91853497 |
| 135 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.91815712 |
| 136 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91812472 |
| 137 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.90590741 |
| 138 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.89524595 |
| 139 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89428878 |
| 140 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.89134327 |
| 141 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88905631 |
| 142 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88905631 |
| 143 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.88530447 |
| 144 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88449014 |
| 145 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88393450 |
| 146 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87556262 |
| 147 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87171835 |
| 148 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85336774 |
| 149 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.85097778 |
| 150 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84884954 |
| 151 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84773411 |
| 152 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.84567063 |
| 153 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84565648 |
| 154 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.84268524 |
| 155 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.84093177 |
| 156 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.83693518 |
| 157 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.83556816 |
| 158 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83506034 |
| 159 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.83469038 |
| 160 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.83469038 |
| 161 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83153918 |
| 162 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82976190 |
| 163 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82942438 |
| 164 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.82792650 |
| 165 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.82768186 |
| 166 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82274007 |
| 167 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82074372 |
| 168 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.81394970 |
| 169 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81243540 |
| 170 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.80893901 |
| 171 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.80513624 |
| 172 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.79415068 |
| 173 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79143076 |
| 174 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.78691121 |
| 175 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78591640 |
| 176 | KDM2B_26808549_Chip-Seq_K562_Human | 0.78483069 |
| 177 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.77653157 |
| 178 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.77646940 |
| 179 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76988190 |
| 180 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76778060 |
| 181 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76605115 |
| 182 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.76180735 |
| 183 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.75733701 |
| 184 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.75082081 |
| 185 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.74689398 |
| 186 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.74558910 |
| 187 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.74427778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 5.50318162 |
| 2 | * MP0002837_dystrophic_cardiac_calcinosis | 5.17592776 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.72590366 |
| 4 | * MP0003646_muscle_fatigue | 4.68428351 |
| 5 | MP0000749_muscle_degeneration | 4.44937874 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.23051635 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.11936670 |
| 8 | MP0005330_cardiomyopathy | 3.60079854 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.38347287 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.33705858 |
| 11 | MP0006292_abnormal_olfactory_placode | 3.33294452 |
| 12 | * MP0004130_abnormal_muscle_cell | 3.30488316 |
| 13 | MP0000750_abnormal_muscle_regeneration | 3.07352082 |
| 14 | MP0005670_abnormal_white_adipose | 2.92971743 |
| 15 | * MP0005620_abnormal_muscle_contractility | 2.89403962 |
| 16 | * MP0002106_abnormal_muscle_physiology | 2.86788527 |
| 17 | MP0002972_abnormal_cardiac_muscle | 2.81809456 |
| 18 | MP0002269_muscular_atrophy | 2.63680431 |
| 19 | MP0000747_muscle_weakness | 2.59153131 |
| 20 | * MP0000759_abnormal_skeletal_muscle | 2.49648714 |
| 21 | MP0010630_abnormal_cardiac_muscle | 2.39059573 |
| 22 | MP0003137_abnormal_impulse_conducting | 2.35978590 |
| 23 | * MP0005369_muscle_phenotype | 2.35375249 |
| 24 | MP0005646_abnormal_pituitary_gland | 2.35095504 |
| 25 | * MP0005385_cardiovascular_system_phenoty | 2.33528755 |
| 26 | * MP0001544_abnormal_cardiovascular_syste | 2.33528755 |
| 27 | MP0004484_altered_response_of | 2.30589234 |
| 28 | * MP0005666_abnormal_adipose_tissue | 2.28203818 |
| 29 | MP0006138_congestive_heart_failure | 2.22367295 |
| 30 | MP0002653_abnormal_ependyma_morphology | 2.11845267 |
| 31 | * MP0008775_abnormal_heart_ventricle | 2.10687316 |
| 32 | MP0008789_abnormal_olfactory_epithelium | 2.09431415 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 2.06918315 |
| 34 | MP0000537_abnormal_urethra_morphology | 2.03848101 |
| 35 | MP0004233_abnormal_muscle_weight | 1.99945702 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.97472777 |
| 37 | MP0003011_delayed_dark_adaptation | 1.96367254 |
| 38 | MP0003221_abnormal_cardiomyocyte_apopto | 1.96314120 |
| 39 | MP0003828_pulmonary_edema | 1.95608250 |
| 40 | MP0000049_abnormal_middle_ear | 1.89514108 |
| 41 | MP0003122_maternal_imprinting | 1.88506745 |
| 42 | MP0002332_abnormal_exercise_endurance | 1.81792475 |
| 43 | MP0009250_abnormal_appendicular_skeleto | 1.81668923 |
| 44 | MP0002160_abnormal_reproductive_system | 1.81536143 |
| 45 | MP0001485_abnormal_pinna_reflex | 1.77437001 |
| 46 | MP0003879_abnormal_hair_cell | 1.74177200 |
| 47 | MP0009053_abnormal_anal_canal | 1.73152211 |
| 48 | MP0002736_abnormal_nociception_after | 1.69532177 |
| 49 | MP0001968_abnormal_touch/_nociception | 1.66632798 |
| 50 | MP0004085_abnormal_heartbeat | 1.65391154 |
| 51 | * MP0005375_adipose_tissue_phenotype | 1.64707003 |
| 52 | MP0004133_heterotaxia | 1.58468625 |
| 53 | MP0002971_abnormal_brown_adipose | 1.50492927 |
| 54 | MP0002102_abnormal_ear_morphology | 1.47871866 |
| 55 | MP0000631_abnormal_neuroendocrine_gland | 1.42248536 |
| 56 | MP0004142_abnormal_muscle_tone | 1.42152267 |
| 57 | MP0003950_abnormal_plasma_membrane | 1.40950615 |
| 58 | MP0004885_abnormal_endolymph | 1.38573865 |
| 59 | MP0003938_abnormal_ear_development | 1.37860568 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.35043919 |
| 61 | MP0002272_abnormal_nervous_system | 1.33634605 |
| 62 | MP0004510_myositis | 1.29978685 |
| 63 | MP0002127_abnormal_cardiovascular_syste | 1.28554307 |
| 64 | MP0003121_genomic_imprinting | 1.25466790 |
| 65 | MP0000013_abnormal_adipose_tissue | 1.25463729 |
| 66 | MP0005389_reproductive_system_phenotype | 1.25394897 |
| 67 | MP0002108_abnormal_muscle_morphology | 1.24729286 |
| 68 | * MP0004185_abnormal_adipocyte_glucose | 1.23656388 |
| 69 | MP0000003_abnormal_adipose_tissue | 1.20748398 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 1.18741582 |
| 71 | MP0003705_abnormal_hypodermis_morpholog | 1.18540485 |
| 72 | MP0000026_abnormal_inner_ear | 1.16365594 |
| 73 | MP0003123_paternal_imprinting | 1.14124110 |
| 74 | MP0009379_abnormal_foot_pigmentation | 1.13783678 |
| 75 | MP0001905_abnormal_dopamine_level | 1.13297989 |
| 76 | MP0000678_abnormal_parathyroid_gland | 1.08405426 |
| 77 | MP0002735_abnormal_chemical_nociception | 1.07242643 |
| 78 | MP0005275_abnormal_skin_tensile | 1.07044072 |
| 79 | MP0002234_abnormal_pharynx_morphology | 1.06775945 |
| 80 | MP0000733_abnormal_muscle_development | 1.05910449 |
| 81 | MP0002638_abnormal_pupillary_reflex | 1.05709290 |
| 82 | MP0001529_abnormal_vocalization | 1.04402397 |
| 83 | MP0008872_abnormal_physiological_respon | 1.04022098 |
| 84 | MP0002733_abnormal_thermal_nociception | 1.03665590 |
| 85 | MP0005394_taste/olfaction_phenotype | 1.03050090 |
| 86 | MP0005499_abnormal_olfactory_system | 1.03050090 |
| 87 | MP0006072_abnormal_retinal_apoptosis | 1.03048948 |
| 88 | * MP0000266_abnormal_heart_morphology | 1.02964292 |
| 89 | MP0005551_abnormal_eye_electrophysiolog | 1.02670713 |
| 90 | MP0009745_abnormal_behavioral_response | 1.02638383 |
| 91 | MP0006276_abnormal_autonomic_nervous | 0.99780167 |
| 92 | MP0003567_abnormal_fetal_cardiomyocyte | 0.99659280 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.99456997 |
| 94 | MP0001963_abnormal_hearing_physiology | 0.98006697 |
| 95 | MP0003942_abnormal_urinary_system | 0.97600603 |
| 96 | MP0001486_abnormal_startle_reflex | 0.97350333 |
| 97 | MP0002163_abnormal_gland_morphology | 0.96516964 |
| 98 | MP0005266_abnormal_metabolism | 0.96086972 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.95885838 |
| 100 | MP0002249_abnormal_larynx_morphology | 0.94857398 |
| 101 | MP0004147_increased_porphyrin_level | 0.94287877 |
| 102 | * MP0000343_altered_response_to | 0.93756944 |
| 103 | MP0003937_abnormal_limbs/digits/tail_de | 0.93212849 |
| 104 | MP0005165_increased_susceptibility_to | 0.91212828 |
| 105 | MP0001984_abnormal_olfaction | 0.90701681 |
| 106 | MP0003890_abnormal_embryonic-extraembry | 0.90638637 |
| 107 | MP0002734_abnormal_mechanical_nocicepti | 0.90019604 |
| 108 | MP0001440_abnormal_grooming_behavior | 0.89715727 |
| 109 | MP0002822_catalepsy | 0.89163240 |
| 110 | MP0003279_aneurysm | 0.87899375 |
| 111 | MP0003119_abnormal_digestive_system | 0.87190338 |
| 112 | MP0002932_abnormal_joint_morphology | 0.85303660 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.85144870 |
| 114 | MP0004924_abnormal_behavior | 0.85144870 |
| 115 | MP0010030_abnormal_orbit_morphology | 0.85019847 |
| 116 | MP0002067_abnormal_sensory_capabilities | 0.80540206 |
| 117 | MP0001970_abnormal_pain_threshold | 0.79296100 |
| 118 | MP0005535_abnormal_body_temperature | 0.79184277 |
| 119 | MP0002752_abnormal_somatic_nervous | 0.78866374 |
| 120 | * MP0005334_abnormal_fat_pad | 0.77917081 |
| 121 | MP0004742_abnormal_vestibular_system | 0.77711648 |
| 122 | MP0002064_seizures | 0.77002237 |
| 123 | MP0004043_abnormal_pH_regulation | 0.76893162 |
| 124 | MP0003787_abnormal_imprinting | 0.76586940 |
| 125 | * MP0002078_abnormal_glucose_homeostasis | 0.76437838 |
| 126 | MP0008961_abnormal_basal_metabolism | 0.74970093 |
| 127 | MP0009384_cardiac_valve_regurgitation | 0.74423210 |
| 128 | * MP0000230_abnormal_systemic_arterial | 0.73744567 |
| 129 | MP0003566_abnormal_cell_adhesion | 0.73259221 |
| 130 | MP0010368_abnormal_lymphatic_system | 0.71509701 |
| 131 | MP0002909_abnormal_adrenal_gland | 0.69963493 |
| 132 | MP0002128_abnormal_blood_circulation | 0.69590190 |
| 133 | MP0004272_abnormal_basement_membrane | 0.68093844 |
| 134 | MP0003806_abnormal_nucleotide_metabolis | 0.67123472 |
| 135 | MP0002970_abnormal_white_adipose | 0.66066272 |
| 136 | MP0005319_abnormal_enzyme/_coenzyme | 0.65662115 |
| 137 | * MP0002118_abnormal_lipid_homeostasis | 0.64659614 |
| 138 | MP0001879_abnormal_lymphatic_vessel | 0.63644802 |
| 139 | * MP0009115_abnormal_fat_cell | 0.61931225 |
| 140 | MP0010329_abnormal_lipoprotein_level | 0.51203491 |
| 141 | MP0005623_abnormal_meninges_morphology | 0.49723027 |
| 142 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48682875 |
| 143 | MP0003948_abnormal_gas_homeostasis | 0.48165912 |
| 144 | * MP0005452_abnormal_adipose_tissue | 0.47559984 |
| 145 | MP0003959_abnormal_lean_body | 0.45949511 |
| 146 | MP0003045_fibrosis | 0.45722231 |
| 147 | MP0000767_abnormal_smooth_muscle | 0.44601891 |
| 148 | MP0003656_abnormal_erythrocyte_physiolo | 0.43405710 |
| 149 | MP0005448_abnormal_energy_balance | 0.42129048 |
| 150 | MP0003191_abnormal_cellular_cholesterol | 0.41104485 |
| 151 | MP0009780_abnormal_chondrocyte_physiolo | 0.39571493 |
| 152 | MP0005187_abnormal_penis_morphology | 0.39297506 |
| 153 | MP0001727_abnormal_embryo_implantation | 0.36954697 |
| 154 | MP0005332_abnormal_amino_acid | 0.36507736 |
| 155 | MP0002925_abnormal_cardiovascular_devel | 0.36387083 |
| 156 | MP0001614_abnormal_blood_vessel | 0.35139773 |
| 157 | MP0005451_abnormal_body_composition | 0.33492511 |
| 158 | MP0001661_extended_life_span | 0.28921298 |
| 159 | MP0001784_abnormal_fluid_regulation | 0.28659688 |
| 160 | MP0001958_emphysema | 0.28477023 |
| 161 | MP0005376_homeostasis/metabolism_phenot | 0.28202722 |
| 162 | MP0000249_abnormal_blood_vessel | 0.27935057 |
| 163 | MP0005595_abnormal_vascular_smooth | 0.27511666 |
| 164 | MP0005167_abnormal_blood-brain_barrier | 0.26994441 |
| 165 | MP0009643_abnormal_urine_homeostasis | 0.26314234 |
| 166 | * MP0000609_abnormal_liver_physiology | 0.26010672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 7.02307214 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 6.56305172 |
| 3 | Sudden death (HP:0001699) | 6.43632117 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.42335161 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.29945677 |
| 6 | Muscle fiber splitting (HP:0003555) | 5.90975293 |
| 7 | Myoglobinuria (HP:0002913) | 5.84550727 |
| 8 | Ventricular tachycardia (HP:0004756) | 5.50867813 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.19002735 |
| 10 | Abnormality of the calf musculature (HP:0001430) | 4.90889953 |
| 11 | Difficulty running (HP:0009046) | 4.86956068 |
| 12 | Muscle fiber inclusion bodies (HP:0100299) | 4.76673031 |
| 13 | Increased connective tissue (HP:0009025) | 4.65321999 |
| 14 | Rhabdomyolysis (HP:0003201) | 4.63938723 |
| 15 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.58450714 |
| 16 | Lipoatrophy (HP:0100578) | 4.44578987 |
| 17 | Atrial fibrillation (HP:0005110) | 4.44104516 |
| 18 | Subaortic stenosis (HP:0001682) | 4.40983996 |
| 19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.40983996 |
| 20 | Type 1 muscle fiber predominance (HP:0003803) | 4.30655390 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 4.25184056 |
| 22 | Absent phalangeal crease (HP:0006109) | 4.22319522 |
| 23 | Cutaneous melanoma (HP:0012056) | 4.15543536 |
| 24 | Primary atrial arrhythmia (HP:0001692) | 4.13555914 |
| 25 | Right ventricular cardiomyopathy (HP:0011663) | 4.05148384 |
| 26 | Supraventricular tachycardia (HP:0004755) | 3.98904374 |
| 27 | Nemaline bodies (HP:0003798) | 3.95229916 |
| 28 | Supraventricular arrhythmia (HP:0005115) | 3.92573626 |
| 29 | Myotonia (HP:0002486) | 3.86049022 |
| 30 | Bundle branch block (HP:0011710) | 3.71758211 |
| 31 | Dilated cardiomyopathy (HP:0001644) | 3.71582084 |
| 32 | Asymmetric septal hypertrophy (HP:0001670) | 3.70533807 |
| 33 | Palpitations (HP:0001962) | 3.66813230 |
| 34 | Muscle stiffness (HP:0003552) | 3.57022494 |
| 35 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.45902514 |
| 36 | Hyperglycinemia (HP:0002154) | 3.42782578 |
| 37 | Abnormal finger flexion creases (HP:0006143) | 3.38798494 |
| 38 | Syncope (HP:0001279) | 3.36223245 |
| 39 | Methylmalonic acidemia (HP:0002912) | 3.35768200 |
| 40 | Increased variability in muscle fiber diameter (HP:0003557) | 3.25645080 |
| 41 | Difficulty climbing stairs (HP:0003551) | 3.22298074 |
| 42 | Prolonged QT interval (HP:0001657) | 3.18455689 |
| 43 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.18103624 |
| 44 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.11719444 |
| 45 | Heart block (HP:0012722) | 3.09667954 |
| 46 | Ventricular arrhythmia (HP:0004308) | 3.07647709 |
| 47 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.00135316 |
| 48 | Atrioventricular block (HP:0001678) | 2.97097749 |
| 49 | Methylmalonic aciduria (HP:0012120) | 2.96147693 |
| 50 | Distal arthrogryposis (HP:0005684) | 2.93018683 |
| 51 | Abnormal atrioventricular conduction (HP:0005150) | 2.92661496 |
| 52 | Neck muscle weakness (HP:0000467) | 2.88365978 |
| 53 | Nephronophthisis (HP:0000090) | 2.87056390 |
| 54 | Ketoacidosis (HP:0001993) | 2.86851653 |
| 55 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.85936105 |
| 56 | Myopathic facies (HP:0002058) | 2.80712845 |
| 57 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.76047242 |
| 58 | Fibular aplasia (HP:0002990) | 2.74906560 |
| 59 | Hepatic necrosis (HP:0002605) | 2.74584999 |
| 60 | Round ear (HP:0100830) | 2.69072911 |
| 61 | Areflexia of lower limbs (HP:0002522) | 2.67563635 |
| 62 | Increased muscle lipid content (HP:0009058) | 2.66355135 |
| 63 | Distal lower limb muscle weakness (HP:0009053) | 2.64670648 |
| 64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.63561850 |
| 65 | Hypoglycemic coma (HP:0001325) | 2.63456244 |
| 66 | Morphological abnormality of the middle ear (HP:0008609) | 2.62167516 |
| 67 | Short 1st metacarpal (HP:0010034) | 2.55598636 |
| 68 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.55598636 |
| 69 | Ventricular fibrillation (HP:0001663) | 2.55237058 |
| 70 | True hermaphroditism (HP:0010459) | 2.54100220 |
| 71 | Rimmed vacuoles (HP:0003805) | 2.49041455 |
| 72 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.47790109 |
| 73 | Facial diplegia (HP:0001349) | 2.47047755 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.46403287 |
| 75 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.46403287 |
| 76 | Congenital stationary night blindness (HP:0007642) | 2.40690454 |
| 77 | Abnormality of midbrain morphology (HP:0002418) | 2.39981063 |
| 78 | Molar tooth sign on MRI (HP:0002419) | 2.39981063 |
| 79 | Short femoral neck (HP:0100864) | 2.37323253 |
| 80 | Acute necrotizing encephalopathy (HP:0006965) | 2.36057959 |
| 81 | Limb-girdle muscle atrophy (HP:0003797) | 2.35020571 |
| 82 | Cerebral palsy (HP:0100021) | 2.32037823 |
| 83 | Abnormality of the nasal septum (HP:0000419) | 2.31347109 |
| 84 | Testicular atrophy (HP:0000029) | 2.30491172 |
| 85 | Pancreatic cysts (HP:0001737) | 2.30104237 |
| 86 | Short hallux (HP:0010109) | 2.29340854 |
| 87 | Abnormal EKG (HP:0003115) | 2.28849546 |
| 88 | Meningioma (HP:0002858) | 2.28800000 |
| 89 | Hepatocellular necrosis (HP:0001404) | 2.26808838 |
| 90 | Left ventricular hypertrophy (HP:0001712) | 2.26096245 |
| 91 | Ketosis (HP:0001946) | 2.25563804 |
| 92 | Hyperglycinuria (HP:0003108) | 2.23313939 |
| 93 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.22943584 |
| 94 | Decreased circulating renin level (HP:0003351) | 2.22536944 |
| 95 | Abnormality of the 1st metacarpal (HP:0010009) | 2.22096473 |
| 96 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.21234102 |
| 97 | Hypoplastic ischia (HP:0003175) | 2.20493797 |
| 98 | Ulnar deviation of the wrist (HP:0003049) | 2.20301722 |
| 99 | Conjunctival hamartoma (HP:0100780) | 2.19653393 |
| 100 | Abnormality of alanine metabolism (HP:0010916) | 2.19363343 |
| 101 | Hyperalaninemia (HP:0003348) | 2.19363343 |
| 102 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.19363343 |
| 103 | Acute encephalopathy (HP:0006846) | 2.19032001 |
| 104 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.18434770 |
| 105 | Muscular dystrophy (HP:0003560) | 2.18380920 |
| 106 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.17769656 |
| 107 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.14906316 |
| 108 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.14529358 |
| 109 | Waddling gait (HP:0002515) | 2.13282157 |
| 110 | Abnormality of the renal medulla (HP:0100957) | 2.12328249 |
| 111 | Humeroradial synostosis (HP:0003041) | 2.11646789 |
| 112 | Synostosis involving the elbow (HP:0003938) | 2.11646789 |
| 113 | Asplenia (HP:0001746) | 2.08997618 |
| 114 | Pancreatic fibrosis (HP:0100732) | 2.08706525 |
| 115 | Proximal amyotrophy (HP:0007126) | 2.08027884 |
| 116 | Generalized muscle weakness (HP:0003324) | 2.07943052 |
| 117 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.07193340 |
| 118 | Palmoplantar keratoderma (HP:0000982) | 2.07045908 |
| 119 | Cerebral edema (HP:0002181) | 2.06393264 |
| 120 | Scapular winging (HP:0003691) | 2.06351530 |
| 121 | Mesomelia (HP:0003027) | 2.06243673 |
| 122 | Agitation (HP:0000713) | 2.05327855 |
| 123 | EMG: neuropathic changes (HP:0003445) | 2.05050735 |
| 124 | Exercise intolerance (HP:0003546) | 2.04892946 |
| 125 | Gowers sign (HP:0003391) | 2.04372957 |
| 126 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.02764584 |
| 127 | Oligomenorrhea (HP:0000876) | 2.02570002 |
| 128 | Genetic anticipation (HP:0003743) | 2.02287434 |
| 129 | Septo-optic dysplasia (HP:0100842) | 2.00547518 |
| 130 | Frequent falls (HP:0002359) | 1.99798853 |
| 131 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.99580882 |
| 132 | Hip contracture (HP:0003273) | 1.99261136 |
| 133 | Distal lower limb amyotrophy (HP:0008944) | 1.98796603 |
| 134 | Progressive macrocephaly (HP:0004481) | 1.98286707 |
| 135 | Increased intramyocellular lipid droplets (HP:0012240) | 1.97820782 |
| 136 | Hypoplasia of the uterus (HP:0000013) | 1.95894418 |
| 137 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.95618901 |
| 138 | Maternal diabetes (HP:0009800) | 1.94065776 |
| 139 | Abnormality of the ischium (HP:0003174) | 1.92123586 |
| 140 | Mitochondrial inheritance (HP:0001427) | 1.92072924 |
| 141 | Lactic acidosis (HP:0003128) | 1.90990307 |
| 142 | Synostosis of carpal bones (HP:0005048) | 1.90880138 |
| 143 | Limb-girdle muscle weakness (HP:0003325) | 1.89692575 |
| 144 | Congenital, generalized hypertrichosis (HP:0004540) | 1.89080496 |
| 145 | Spinal rigidity (HP:0003306) | 1.88923777 |
| 146 | Increased CSF lactate (HP:0002490) | 1.87698594 |
| 147 | Broad metatarsal (HP:0001783) | 1.87188574 |
| 148 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.84296547 |
| 149 | Visual hallucinations (HP:0002367) | 1.83051152 |
| 150 | Hamartoma of the eye (HP:0010568) | 1.82719643 |
| 151 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.81927714 |
| 152 | Lymphangioma (HP:0100764) | 1.81624501 |
| 153 | Abnormality of glycine metabolism (HP:0010895) | 1.81446574 |
| 154 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.76398780 |
| 155 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.75903452 |
| 156 | Metabolic alkalosis (HP:0200114) | 1.72266187 |
| 157 | Abnormality of the 4th metacarpal (HP:0010012) | 1.71268149 |
| 158 | Abnormality of the renal collecting system (HP:0004742) | 1.71175407 |
| 159 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.69625318 |
| 160 | Osteomalacia (HP:0002749) | 1.67767047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.41511279 |
| 2 | FRK | 5.15536734 |
| 3 | OBSCN | 5.07953520 |
| 4 | PHKG2 | 4.45614569 |
| 5 | PHKG1 | 4.45614569 |
| 6 | PDK4 | 3.67351115 |
| 7 | PDK3 | 3.67351115 |
| 8 | TRIB3 | 3.25745018 |
| 9 | BCKDK | 3.18320096 |
| 10 | LMTK2 | 3.16164020 |
| 11 | MYLK | 2.78782875 |
| 12 | DMPK | 2.66517265 |
| 13 | MAP3K9 | 2.56950170 |
| 14 | PKN2 | 2.38775806 |
| 15 | PDK2 | 2.29317178 |
| 16 | GRK1 | 2.24079734 |
| 17 | NEK1 | 2.17241965 |
| 18 | PIK3CA | 2.06641578 |
| 19 | TLK1 | 2.06355149 |
| 20 | PINK1 | 2.06018486 |
| 21 | ADRBK2 | 1.90418570 |
| 22 | FGFR2 | 1.80075372 |
| 23 | STK16 | 1.79253999 |
| 24 | TIE1 | 1.61562235 |
| 25 | MUSK | 1.60401822 |
| 26 | MAP2K3 | 1.43504146 |
| 27 | MAP3K13 | 1.38349294 |
| 28 | CAMK1D | 1.34765924 |
| 29 | TXK | 1.33524250 |
| 30 | RIPK4 | 1.32661297 |
| 31 | MAPK13 | 1.29108827 |
| 32 | MAP3K7 | 1.25545070 |
| 33 | DYRK2 | 1.22656049 |
| 34 | TAOK3 | 1.20162451 |
| 35 | NME1 | 1.19234899 |
| 36 | STK24 | 1.16566554 |
| 37 | PRKAA2 | 1.16070826 |
| 38 | RIPK1 | 1.14135210 |
| 39 | PIK3CG | 1.12587201 |
| 40 | SIK1 | 1.12505315 |
| 41 | BMPR1B | 1.12293776 |
| 42 | MAPK12 | 1.11735366 |
| 43 | STK39 | 1.05786891 |
| 44 | PRKAA1 | 1.02285694 |
| 45 | WNK3 | 1.01498033 |
| 46 | PRKD1 | 1.01292320 |
| 47 | CAMK1G | 1.00196268 |
| 48 | MARK1 | 0.98480121 |
| 49 | CASK | 0.98262370 |
| 50 | PRKD2 | 0.94975405 |
| 51 | ILK | 0.93477913 |
| 52 | RPS6KA2 | 0.92847420 |
| 53 | MAP4K2 | 0.92725223 |
| 54 | GRK7 | 0.91812355 |
| 55 | MAPKAPK3 | 0.91746145 |
| 56 | PAK3 | 0.90535569 |
| 57 | SGK494 | 0.88152009 |
| 58 | SGK223 | 0.88152009 |
| 59 | INSRR | 0.87009273 |
| 60 | MAP3K4 | 0.86544821 |
| 61 | NTRK2 | 0.85676458 |
| 62 | SGK2 | 0.85019181 |
| 63 | CAMK2D | 0.83196672 |
| 64 | PDGFRA | 0.83173052 |
| 65 | STK11 | 0.81722302 |
| 66 | MAP3K3 | 0.74980781 |
| 67 | ADRBK1 | 0.74795926 |
| 68 | DAPK2 | 0.73294868 |
| 69 | ROCK1 | 0.72364304 |
| 70 | PRKCQ | 0.69347997 |
| 71 | TRPM7 | 0.68737467 |
| 72 | WNK4 | 0.67079282 |
| 73 | ZAK | 0.66074759 |
| 74 | NEK9 | 0.65540658 |
| 75 | FLT3 | 0.64017219 |
| 76 | TGFBR2 | 0.63489322 |
| 77 | MAP2K2 | 0.60691633 |
| 78 | STK38L | 0.59028484 |
| 79 | MAPK4 | 0.58913147 |
| 80 | ACVR1B | 0.58892936 |
| 81 | ABL2 | 0.56187742 |
| 82 | MAP3K5 | 0.55662582 |
| 83 | OXSR1 | 0.55343535 |
| 84 | CDC42BPA | 0.55253031 |
| 85 | PKN1 | 0.55213476 |
| 86 | ITK | 0.54936718 |
| 87 | EPHB1 | 0.54546133 |
| 88 | STK4 | 0.53539407 |
| 89 | NTRK3 | 0.52578883 |
| 90 | MAPKAPK5 | 0.51613540 |
| 91 | IKBKB | 0.51013528 |
| 92 | PRKCG | 0.50045292 |
| 93 | NUAK1 | 0.48910038 |
| 94 | PRKCZ | 0.47916745 |
| 95 | PDPK1 | 0.47652184 |
| 96 | MAP2K4 | 0.46362604 |
| 97 | CAMK4 | 0.45643606 |
| 98 | MAP2K7 | 0.45554093 |
| 99 | LATS1 | 0.44702379 |
| 100 | STK38 | 0.43043766 |
| 101 | ICK | 0.41887492 |
| 102 | DAPK3 | 0.41598709 |
| 103 | ERBB2 | 0.40873410 |
| 104 | DYRK3 | 0.40417872 |
| 105 | MAPK11 | 0.40350913 |
| 106 | CAMK1 | 0.40229985 |
| 107 | ERN1 | 0.39858720 |
| 108 | EPHB2 | 0.39838127 |
| 109 | WNK1 | 0.39659528 |
| 110 | AKT2 | 0.39645802 |
| 111 | PRKACB | 0.39449971 |
| 112 | GRK5 | 0.39302637 |
| 113 | CSNK1A1 | 0.39047181 |
| 114 | PRKACG | 0.38884559 |
| 115 | PRKCA | 0.38392776 |
| 116 | MAPK15 | 0.37370168 |
| 117 | VRK1 | 0.36839237 |
| 118 | PDK1 | 0.36586067 |
| 119 | ROCK2 | 0.36063211 |
| 120 | VRK2 | 0.35518452 |
| 121 | PTK6 | 0.35513484 |
| 122 | CAMK2G | 0.35499265 |
| 123 | RPS6KC1 | 0.35206519 |
| 124 | RPS6KL1 | 0.35206519 |
| 125 | KDR | 0.33842398 |
| 126 | KIT | 0.33807238 |
| 127 | MAP2K6 | 0.33702114 |
| 128 | PTK2B | 0.33227253 |
| 129 | PRKACA | 0.32061952 |
| 130 | CAMKK2 | 0.31523820 |
| 131 | MTOR | 0.30094306 |
| 132 | RPS6KA6 | 0.28493163 |
| 133 | CSNK1G2 | 0.27919170 |
| 134 | PRKCH | 0.27700407 |
| 135 | TAOK1 | 0.27680106 |
| 136 | CAMK2B | 0.27286634 |
| 137 | CAMK2A | 0.27140912 |
| 138 | LATS2 | 0.27132079 |
| 139 | FGFR4 | 0.26078890 |
| 140 | PRKD3 | 0.25081954 |
| 141 | FGFR3 | 0.23927444 |
| 142 | JAK1 | 0.23651395 |
| 143 | FER | 0.23412580 |
| 144 | MAP2K1 | 0.22749484 |
| 145 | RPS6KA1 | 0.22532855 |
| 146 | RET | 0.22277616 |
| 147 | SGK3 | 0.21649236 |
| 148 | JAK2 | 0.19140764 |
| 149 | RPS6KA3 | 0.17602633 |
| 150 | PRKCE | 0.16689511 |
| 151 | EEF2K | 0.15600479 |
| 152 | LRRK2 | 0.15180881 |
| 153 | PRKG1 | 0.14249597 |
| 154 | MAP3K11 | 0.13936514 |
| 155 | PDGFRB | 0.12503386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.01861228 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.40536727 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.04609972 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.32471547 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.20904386 |
| 6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.02973565 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.00391726 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.91525527 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.77572609 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.64544339 |
| 11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.58248023 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.55609890 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.43707531 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 2.35737493 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 2.33573211 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.33513114 |
| 17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.18086091 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.17814431 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.14796978 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.94405500 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90845663 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.85640845 |
| 23 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.82439260 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.79763904 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.77727221 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.75001645 |
| 27 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.72941076 |
| 28 | Nicotine addiction_Homo sapiens_hsa05033 | 1.70792371 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.59652963 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55174780 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.48263139 |
| 32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.42148383 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41568495 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.36866373 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35922706 |
| 36 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.35408216 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34304048 |
| 38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.32300132 |
| 39 | Olfactory transduction_Homo sapiens_hsa04740 | 1.31568386 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30333162 |
| 41 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.29951593 |
| 42 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.24956739 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 1.24525647 |
| 44 | * Insulin resistance_Homo sapiens_hsa04931 | 1.22876829 |
| 45 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.20418120 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18760056 |
| 47 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 1.14160746 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13924685 |
| 49 | Circadian entrainment_Homo sapiens_hsa04713 | 1.09622781 |
| 50 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 1.07966457 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.06950136 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.06350156 |
| 53 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.00710888 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 0.95985649 |
| 55 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.94496180 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.89683168 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88901991 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.88264094 |
| 59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87802024 |
| 60 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87131539 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.86408706 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.85417113 |
| 63 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.84957263 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84091696 |
| 65 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.83500700 |
| 66 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81106184 |
| 67 | RNA polymerase_Homo sapiens_hsa03020 | 0.79716751 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.77271263 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.76930836 |
| 70 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75653803 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73987595 |
| 72 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73495308 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.72579229 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71703907 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69397206 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69227874 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67493742 |
| 78 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67347762 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67320322 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66834687 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64353168 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63521223 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.63325446 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.61682908 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61077900 |
| 86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60339525 |
| 87 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.60081454 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59064887 |
| 89 | Homologous recombination_Homo sapiens_hsa03440 | 0.58938106 |
| 90 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58815316 |
| 91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57640295 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57089133 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55713318 |
| 94 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55108546 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.54564383 |
| 96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53571956 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52276275 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52115745 |
| 99 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51407908 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.50327523 |
| 101 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49856499 |
| 102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48897698 |
| 103 | Purine metabolism_Homo sapiens_hsa00230 | 0.48375745 |
| 104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48320289 |
| 105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.48160681 |
| 106 | Salivary secretion_Homo sapiens_hsa04970 | 0.46801957 |
| 107 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45869865 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45069958 |
| 109 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.44271779 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41572223 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40131081 |
| 112 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.39245731 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38241417 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34798111 |
| 115 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34761440 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34084145 |
| 117 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33173173 |
| 118 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.31199146 |
| 119 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30227100 |
| 120 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29178700 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | 0.27320618 |
| 122 | Adherens junction_Homo sapiens_hsa04520 | 0.26936032 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26246280 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25336037 |
| 125 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22420596 |
| 126 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.20815929 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.18805640 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.16611127 |
| 129 | Platelet activation_Homo sapiens_hsa04611 | 0.16552355 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15528079 |
| 131 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.13380920 |
| 132 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.12522440 |
| 133 | Insulin secretion_Homo sapiens_hsa04911 | 0.12424272 |
| 134 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.11922944 |
| 135 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.11191172 |
| 136 | ABC transporters_Homo sapiens_hsa02010 | 0.11108005 |
| 137 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10626845 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10610324 |
| 139 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.08890397 |
| 140 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.06932764 |
| 141 | Bile secretion_Homo sapiens_hsa04976 | 0.06253519 |
| 142 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.05114107 |
| 143 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.03287074 |
| 144 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.03126947 |
| 145 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02703016 |
| 146 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.02103881 |
| 147 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.01689727 |
| 148 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.01195186 |
| 149 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.00673143 |
| 150 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0069856 |

